Abstract
Diffuse large B-cell lymphoma is associated with varying outcomes, and disparities exist within high-risk disease. Prognostication with the International Prognostic Index anticipates patient outcomes, provides risk stratification, and guides treatment. We used a national database to compare the treatment outcomes from academic and nonacademic centers. We found improved overall survival in each risk category at academic centers.
Original language | English (US) |
---|---|
Pages (from-to) | e174-e183 |
Journal | Clinical Lymphoma, Myeloma and Leukemia |
Volume | 20 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2020 |
All Science Journal Classification (ASJC) codes
- Hematology
- Oncology
- Cancer Research